Mycophenolate mofetil decreases antibody production after cardiac transplantation
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 21 (2) , 282-285
- https://doi.org/10.1016/s1053-2498(01)00335-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Rapid Displacement of Vimentin Intermediate Filaments in Living Endothelial Cells Exposed to FlowCirculation Research, 2000
- Altered Flow–Induced Arterial Remodeling in Vimentin-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Role of antibodies in rejectionCurrent Opinion in Organ Transplantation, 1999
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- MONITORING OF SOLUBLE HLA ALLOANTIGENS AND ANTI-HLA ANTIBODIES IDENTIFIES HEART ALLOGRAFT RECIPIENTS AT RISK OF TRANSPLANT-ASSOCIATED CORONARY ARTERY DISEASE1Transplantation, 1996
- IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23International Immunology, 1993
- Anti-endothelial antibodies and coronary artery disease after cardiac transplantationThe Lancet, 1992
- Lymphocyte‐Selective Antiproliferative and Immunosuppressive Effects of Mycophenolic Acid in MiceScandinavian Journal of Immunology, 1991
- Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionScandinavian Journal of Immunology, 1991
- Suppression of B cell activation by cyclosporin A, FK506 and rapamycinEuropean Journal of Immunology, 1990